RACHEL RUNKLE: Open Payments
NPI 1780921247 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$426 in 23 payments from 11 companies in 2025. Trend: 2023 $93 · 2024 $175 · 2025 $426
Food & beverage: $426
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $68 |
| Evofem Biosciences, Inc. | 4 | $57 |
| Exeltis, USA Inc. | 3 | $50 |
| Astellas Pharma US Inc | 2 | $48 |
| Sumitomo Pharma America, Inc. | 2 | $47 |
| PFIZER INC. | 2 | $37 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $37 |
| Biogen, Inc. | 1 | $28 |
| Vertex Pharmaceuticals Incorporated | 1 | $21 |
| Dexcom, Inc. | 1 | $18 |
Products named: Phexxi, Kyleena, SLYND, Veozah, MYFEMBREE, ABRYSVO, ZURZUVAE, JOURNAVX.
Industry payments across NC — which companies pay providers there.
